HALO logo
halo search icon
Gossamer Bio, Inc.
Gossamer Bio, Inc.
GOSS · NAS

Gossamer Bio, Inc.

US$0.20

Price Arrow-0.0144 (-6.688%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleEngulfing BearishHALO AllHALO Capital EfficiencyHALO Consensus ValueNear Support+3
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Gossamer Bio, Inc. Overview

GOSS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Weak

About GOSS

icon

Telephone

1.858.684.1300

icon

Address

Suite 120, 3115 Merryfield Row, San Diego, CA 92121

Description

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi on October 26, 2015 and is headquartered in San Diego, CA.

GOSS Price Chart

Key Stats

Market Cap

US$50.53M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.16 - 3.87

Trade Value (12mth)

US$2,143,447.00

1 week

-36.68%

1 month

-44.78%

YTD

-92.52%

1 year

-81.44%

All time high

27.15

Key Fundamentals

EPS 3 yr Growth

-72.50%

EBITDA Margin

-334.70%

Operating Cashflow

-$171m

Free Cash Flow Return

-110.30%

ROIC

-109.70%

Interest Coverage

-14.80

Quick Ratio

2.60

Other Data

Shares Outstanding (Fully Diluted)

234m

HALO Sector

Healthcare

Next Company Report Date

12-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

GOSS Announcements

Latest Announcements

DateAnnouncements
18 May 26
16 May 26
16 May 26
10 April 26
24 February 26

GOSS Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-1.18-0.25-0.75locklocklock
EPS (Fully Diluted)
$locklocklocklock-1.18-0.25-0.75locklocklock
Growth
%locklocklocklock56.678.8-198.3locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Gossamer Bio, Inc. (GOSS:NAS)?
Halo FAQ
The current share price of Gossamer Bio, Inc. (GOSS:NAS) is USD$0.20.
What is the 52-week high share price for Gossamer Bio, Inc. (GOSS:NAS)?
Halo FAQ
The 52-week high share price for Gossamer Bio, Inc. (GOSS:NAS) is USD$3.87.
What is the 52-week low share price for Gossamer Bio, Inc. (GOSS:NAS)?
Halo FAQ
The 52-week low share price for Gossamer Bio, Inc. (GOSS:NAS) is USD$0.16.
What is the dividend yield for Gossamer Bio, Inc. (GOSS:NAS)?
Halo FAQ
Gossamer Bio, Inc. (GOSS:NAS) does not pay a dividend.
What was Gossamer Bio, Inc. (GOSS:NAS) last dividend payment?
Halo FAQ
Gossamer Bio, Inc. (GOSS:NAS) does not pay a dividend.
What is the franking level for Gossamer Bio, Inc. (GOSS:NAS)?
Halo FAQ
Gossamer Bio, Inc. (GOSS:NAS) has a franking level of 0.00%.
In which sector is Gossamer Bio, Inc. (GOSS:NAS) classified?
Halo FAQ
Gossamer Bio, Inc. (GOSS:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.